RxDoctor Payments Data

Robert Dimasi, DO

Family Medicine · Oldsmar, FLNPI 1699724914

Payments from drug & device makers

$676in general payments, 2019–2025

Across 38 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$172
  • Lilly USA, LLC$116
  • GSK$91
  • Novo Nordisk$78
  • Amarin Pharma, Inc.$46
  • Exact Sciences$44
  • plus $128 from 7 others

What the payments were for

  • Food & beverage$676100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$676 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$28,568
Medicare patients
86
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$23,315
FarxigaDapagliflozin Propanediol20$20,537
MounjaroTirzepatide20$19,216
SynthroidLevothyroxine Sodium18$2,019
Rosuvastatin Calcium102$1,806
Duloxetine Hcl13$623
Levothyroxine Sodium40$590
Ezetimibe20$519
Losartan Potassium41$499
Escitalopram Oxalate24$456
Metoprolol Succinate30$430
ValacyclovirValacyclovir Hcl23$405
Atorvastatin Calcium43$342
Alprazolam43$336
Amlodipine Besylate27$325

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$78$23,31511 claims
AstraZenecaFarxiga$172$20,53720 claims
Lilly USA, LLCMounjaro$116$19,21620 claims
AbbVieSynthroid$16$2,01918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Oldsmar

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →